• Skip to main content
  • Skip to primary sidebar

Aphios

Inspired by Nature, Enabled by Science®

  • Products
    ▼
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      ▼
      • Oncology
        ▼
        • Zindol®
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        ▼
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          ▼
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        ▼
        • APH-1104
        • Xantol™
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        ▼
        • APH-0907
    • Research Chemicals & API’s
      ▼
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine
      • Cyclopamine
      • Cycloposine
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol
      • 8-Gingerol
      • 10-Gingerol
      • Hypericin
      • Hyperforin
      • Hyperforin DCHA
      • Jervine
      • MLA
      • Muldamine
      • Nobiletin
      • Paclitaxel
      • Phloridzin Dihydrate
      • Sclareolide
      • 6-Shogaol
      • Tangeretin
      • Veratramine
    • Equipment
    • Quality of Life Medicines
  • Technology
    ▼
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      ▼
      • CFN
      • PNS
      • PNP
    • Drug Safety
      ▼
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      ▼
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      ▼
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Partnering
    ▼
    • Partnering Overview
      ▼
      • Zindol LLC
    • Pharmaceutical & Biotechnology Partners
    • University Partners
    • Institutional Research Partners
  • Investors
    ▼
    • Investors Overview
      ▼
      • Aphios Pharma LLC
      • Aphios International LLC
  • Resources
    ▼
    • Resources Overview
    • Facilities
    • Intellectual Property
    • Marine Microorganism Library
    • Research Grants & Contracts
  • About
    ▼
    • Company Overview
    • Management & Directors
    • Scientific Advisory Board
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop
  • Products
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      • Oncology
        • Zindol®
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        • APH-1104
        • Xantol™
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        • APH-0907
    • Research Chemicals & API’s
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine
      • Cyclopamine
      • Cycloposine
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol
      • 8-Gingerol
      • 10-Gingerol
      • Hypericin
      • Hyperforin
      • Hyperforin DCHA
      • Jervine
      • MLA
      • Muldamine
      • Nobiletin
      • Paclitaxel
      • Phloridzin Dihydrate
      • Sclareolide
      • 6-Shogaol
      • Tangeretin
      • Veratramine
    • Equipment
    • Quality of Life Medicines
  • Technology
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      • CFN
      • PNS
      • PNP
    • Drug Safety
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Partnering
    • Partnering Overview
      • Zindol LLC
    • Pharmaceutical & Biotechnology Partners
    • University Partners
    • Institutional Research Partners
  • Investors
    • Investors Overview
      • Aphios Pharma LLC
      • Aphios International LLC
  • Resources
    • Resources Overview
    • Facilities
    • Intellectual Property
    • Marine Microorganism Library
    • Research Grants & Contracts
  • About
    • Company Overview
    • Management & Directors
    • Scientific Advisory Board
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop

Press Releases Archive

2016 Press Releases

September 13, 2016 – Aphios to Develop HIV/AIDS Cure Using Combination Drugs

July 12, 2016 – Aphios Awarded Subcontract for Nanoformulation of Super Hydrophobic Anticancer Drug

Primary Sidebar

  • Company Overview
  • Management & Directors
  • Scientific Advisory Board
  • Community Involvement
  • Press Releases
    • Press Releases Archive
      • 2016 Press Releases
      • 2017 Press Releases
    • Aphios International Launches Crowdfunding for Groundbreaking CFI Technology for Convalescent Plasma
    • Aphios Granted Hong Kong Patent for Compound to Treat Neurodegenerative diseases, Virus Latency, Cancer
    • Aphios Granted US Patent for Combination Therapeutic to Treat Neurodegenerative Diseases
    • Oral Nanoparticle-Encapsulated Bryostatin-1 found Effective for Treating Cognitive Deficits in an Alzheimer's Disease Mouse Model
  • Events
  • Careers
    • Chief Financial Officer
    • Mechanical Technician
    • Nanotechnology Technician
    • Senior Mechanical Technician

Aphios

Inspired by Nature, Enabled by Science®

© 2025 Aphios Corporation

Contact Us

  • mail@aphios.com
  • (781) 932-6933
  • 87 Main Street, North Reading, MA 01864 USA
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram
  • Tik Tok